Serotonin/dopamine interaction - Focus on 5-HT2C receptor, a new target of psychotropic drugs

Indian Journal of Experimental Biology

Volumn 40, Issue 12, 2002, Pages 1344-1352

  Di Giovanni, G ^a   Di Matteo, V ^b   Esposito, E ^b  

^a UNIVERSITY OF PALERMO   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; DRUG THERAPY; ELECTROPHYSIOLOGY; NEUROLOGY; PSYCHOPHYSIOLOGY;

NEURONES;

PATHOLOGY;

PSYCHOTROPIC AGENT; SEROTONIN 2C RECEPTOR; SEROTONIN RECEPTOR;

ANIMAL; DRUG EFFECT; REVIEW;

ANIMALS; PSYCHOTROPIC DRUGS; RECEPTOR, SEROTONIN, 5-HT2C; RECEPTORS, SEROTONIN;

EID: 0036897450     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Hervé D, Pickel V M, Tong H J & Beaudet A, Serotonin axon terminals in the ventral tegmental area of the rat: Fine structure and synaptic input to dopaminergic neurons, Brain Res, 435 (1987) 71.
2. Moukhles H, Bosler O, Bolam J P, Vallé A, Umbriaco D, Geffard M & Doucet G, Quantitative and morphometric data indicate precise cellular interactions between serotonin and postsynaptic targets in rat substantia nigra, Neuroscience, 76 (1997) 1159.
3. Azmitia E C & Segal M, An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat, J Comp Neurol, 179 (1978) 641.
4. Pazos A & Palacios J M, Quantitative autoradiographic mapping of serotonin receptors in the rat brain: I -Serotonin-1 receptors, Brain Res, 346 (1985) 205.
5. Barnes N M & Sharp T, A review of central 5-HT receptors and their function, Neuropharmacology, 38 (1999) 1083.
6. 2C receptors, Mol Brain Res, 23 (1994) 163.
7. 2C receptors, Brain Res, 865 (2000) 85.
8. 2C receptor protein in human and rat brain using specific antisera, Neuropharmocology, 34 (1995) 1635.
9. Johnson S W, Mercuri N B & North R A, 5-Hydroxytrypyamine 1 B receptors block the GABAB synaptic potential in rat dopamine neurons, J Neurosci, 12 (1992) 2000.
10. Prisco S, Pagannone S & Esposito E, Serotonin - dopamine interaction in the rat ventral tegmental area: An electrophysiological study in vivo, J Pharmacol Exp Ther, 271 (1994) 83.
11. 2 receptor agonists, Eur J Pharmacol, 264 (1994) 325.
12. Prisco S & Esposito E, Differential effects of acute and chronic flouxetine administration on the spontaneous activity of dopaminergic neurons in the ventral tegmental area, Br J Pharmacol, 116 (1995) 1923.
13. Boess F G & Martin I L, Molecular biology of 5-HT receptors, Neuropharmacology, 33 (1994) 275.
14. Hoyer D, Clarke D E, Fozard J R, Hartig P R, Martin G R, Mylecharane E J, Saxena P R & Humprey P P A, International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin), Pharmacol Rev, 46 (1994) 157.
15. Maj J & Moryl E, Effects of sertraline and citalopram given repeatedly on the responsiveness of 5-HT receptor subpopulations, J Neural Transm: Gen Sec, 88 (1992) 143.
16. Di Mascio M & Esposito E, The degree of inhibition of dopaminergic neurons in the ventral tegmental area induced by selective serotonin reuptake inhibitors is a function of the density power spectrum of the interspike interval, Neuroscience, 79 (1997) 957.
17. 2c/2B receptor agonists: A combined in vivo electrophysiological and microdialysis study, Synapse, 35 (2000) 53.
18. 2B receptor antagonist with anxiolytic-like properties, Br J Pharmacol, 117 (1996) 427.
19. 2c/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: A combined in vivo electrophysiological and microdialysis study, Neuroscience, 91 (1999) 587.
20. 2c/2B receptors enhances dopamine release in the rat nucleus accumbens, Neuropharmacology, 37 (1998) 265.
21. 2C receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic pathways: a combined dialysis and electro-physiological analysis in the rat, Synapse, 36 (2000) 205.
22. 2C receptor antagonist, Neuropharmacology, 36 (1997) 609.
23. 2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system, Neuropharmacology, 38 (1999) 1195.
24. 2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo, Neuropharmacology, 37 (1998) 953.
25. 2C/2B receptor antagonists: Neurochemical and behavioural studies, Neuropharmocology, 39 (2000) 2318.
26. 2C receptors, Neuroscience, 103 (2001) 111.
27. Cervo L & Samanin R, Repeated treatment with imipramine and amitriptyline reduced the immobility of rats in the forced swimming test by enhancing dopamine mechanisms in the nucleus accumbens, J PharmPharmacol, 40 (1988) 155.
28. 2 receptor subtypes: A family reunited, Trends Pharmacol Sci, 16 (1995) 105.
29. 1C receptors and antidepressants, Progr Neurophsychopharmacol Biol Psychiatry, 18 (1994) 563.
30. 2C receptors, Psychopharmacology, 150 (2000) 45.
31. Sampson D, Willner P & Muscat R, Reversal of antidepressant action by dopamine antagonists in an animal model of depression, Psychopharmacology, 104 (1991) 491.
32. Moreau J L, Bourson A, Jenck F, Martin J R & Mortas P, Curative effects of the atypical antidepressant mianserin in the chronic mild stress-induced anhedonia model of depression, J Psychiatr Neurosci, 19 (1994) 51.
33. Willner P, Animal models of depression: Validity and applications, in Depression and Mania: From Neurobiology to Treatment, edited by G Gessa, W Fratta, L Pani and G Serra (Raven Press, New York) 1995, 19.
34. Brown A S & Gershon S, Dopamine and depression, J Neural Transm Psychiatr Sect, 91 (1993) 75.
35. Fibiger H C, Neurobiology of depression: Focus on dopamine, in Depression and mania: From neurobiology to treatment, edited by G Gessa, W Fratta, L Pani and G Serra, (Raven Press, New York) 1995, 1.
36. Deutch A, Moghaddam B, Innis R B, Krystal J H, Aghajanian G K, Bunney B S & Charney D S, Mechanisms of action of atypical antipsychotic drugs: Implications for novel therapeutic strategies for schizophrenia, Schizophr Res, 4 (1991) 121.
37. 2C receptors, J Pharmacol Exp Ther, 295 (2000) 226.
38. 2C receptors on cocaine and food maintained behavior, J Pharmacol Exp Ther, 295 (2000) 1183.
39. 2C receptors reduces the locomotor and rewarding effects of nicotine, Psychopharmacology (2002) (in press).
40. 2C receptors in modifying ethanol self-administration behaviour, Pharmacol Biochem Behav, (2002) (in press).
41. 2C agonists selectively inhibit morphine-induced dopamine efflux in the nucleus accumbens, Brain Res, 781 (1998) 291.
42. Albin R, Young A B & Penney J B, The functional anatomy of basal ganglia disorders, Trends Neurosci, 12 (1989) 366.
43. Hagan J J, Middlemiss D N, Sharp P C & Poste G H, Parkinson's disease: Prospects for improved drug therapy, Trends Pharmacol Sci, 18 (1997) 156.
44. Agid Y, Levodopa: Is toxicity a myth? Neurology, 50 (1998) 858.45.
45. Rodriguez M C, Obeso J A & Olanow C W, Subthalamic nucleus-mediated excitoxicity in Parkinson's disease: a target for neuroprotection, Ann Neurol, 44 (1998) S175 (Suppl).
46. 2C receptor messenger RNA in the basal ganglia of adults rats, J Comp Neurol, 384 (1997) 233.
47. 2 receptors in adult rat brain after destruction of nigrostriatal dopamine neurons: A quantitative autoradiographic study, Brain Res, 606 (1993) 273.
48. 2C receptor binding is increased in the sub-stantia nigra pars reticulata in Parkinson's disease, Mov Disord, 15 (2000) 1064.